Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergy to bumblebees.

Hans de Groot1

  • 1Department of Allergology, Erasmus MC, Rotterdam, The Netherlands. h.degroot@erasmusmc.nl

Current Opinion in Allergy and Clinical Immunology
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Bumblebee stings can cause anaphylaxis, especially in greenhouse workers. Immunotherapy with purified bumblebee venom is effective for those allergic to bumblebee venom, offering a safe treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiphasic anaphylaxis in the emergency and intensive care setting.

BMJ case reports·2026
Same author

[Rectal bleeding in infancy; could it be an allergy?]

Nederlands tijdschrift voor geneeskunde·2026
Same author

The prevalence of peanut-triggered food protein-induced enterocolitis syndrome in a prospective cohort of infants introducing peanut in the first year of life.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

Successful Introduction of Peanut in Sensitized Infants With Reported Reactions at Home.

The journal of allergy and clinical immunology. In practice·2024
Same author

Method to develop a regional guide for the allergenic potential of tree pollen.

The Science of the total environment·2024
Same author

Reactions to peanut at first introduction in infancy are associated with age ≥8 months and severity of eczema.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2023
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Area of Science:

  • Allergy and Immunology
  • Toxicology
  • Occupational Health

Background:

  • Bumblebee stings are rare but can cause severe allergic reactions (anaphylaxis).
  • Increased use of bumblebees in agriculture, particularly tomato cultivation, has led to more reported stings.
  • Occupational exposure in greenhouse settings poses a risk for sensitization and allergic reactions.

Purpose of the Study:

  • To review current literature on bumblebee venom anaphylaxis.
  • To present findings on immunotherapy for bumblebee venom-allergic workers.
  • To differentiate treatment strategies based on venom cross-reactivity.

Main Methods:

  • Literature review of bumblebee venom anaphylaxis and immunotherapy.
  • Analysis of patient sensitization patterns to bumblebee and honeybee venom.

Related Experiment Videos

  • Evaluation of immunotherapy efficacy and tolerance in allergic workers.

    • Main Results:

    • Two patient groups identified: those with cross-reactivity to honeybee venom and those primarily sensitized to bumblebee venom.
    • Honeybee venom immunotherapy may suffice for patients with cross-reactivity.
    • Purified bumblebee venom immunotherapy is recommended for heavily exposed workers with low cross-reactivity to honeybee venom.

    Conclusions:

    • Immunotherapy with purified bumblebee venom demonstrates good tolerance and efficacy.
    • Treatment choice depends on the degree of cross-reactivity with honeybee venom.
    • Avoiding occupational exposure is a preventive measure for severe cases.